Moloney Securities Asset Management, LLC Evaxion Biotech A/S Transaction History

Moloney Securities Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$0.48 - $1.33 $9,600 - $26,600	-20,000 Reduced 64.52%	11,000 $9,000
Q2 2023 Jul 31, 2023	SELL	$1.12 - $1.74 $5,600 - $8,700	-5,000 Reduced 13.89%	31,000 $40,000
Q1 2023 May 12, 2023	BUY	$1.03 - $1.8 $37,080 - $64,800	36,000 New	36,000 $40,000

37.5K

Ticker EVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,977,900
Market Cap $71.2M
Description
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.